Page last updated: 2024-11-03

prazosin and Kidney Stones

prazosin has been researched along with Kidney Stones in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Oestreich, MC1
Vernooij, RW1
Sathianathen, NJ1
Hwang, EC1
Kuntz, GM1
Koziarz, A1
Scales, CD1
Dahm, P1
Yang, TX1
Liao, BH1
Chen, YT1
Li, H1
He, Q1
Liu, QY1
Wang, KJ1

Reviews

2 reviews available for prazosin and Kidney Stones

ArticleYear
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.
    The Cochrane database of systematic reviews, 2020, 11-12, Volume: 11

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; D

2020
A network meta-analysis on the beneficial effect of medical expulsive therapy after extracorporeal shock wave lithotripsy.
    Scientific reports, 2017, 10-31, Volume: 7, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Calcium Channel Blockers; Combined Modality Therapy; Humans

2017